| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
40,010,000 |
| Market
Cap: |
482.92(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.86 - $18.69 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 13.4 |
| Insider 3/6 Months : 14 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Y-mAbs Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Co.'s approved drug DANYELZA® (naxitamab-gqgk) was approved by the U.S. Food and Drug Administration for the treatment, in combination with Granulocyte-Macrophage Colony-Stimulating Factor of pediatric patients one year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who have demonstrated a partial response, minor response, or stable disease to prior therapy.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
218,636 |
558,056 |
762,731 |
| Total Buy Value |
$0 |
$1,530,150 |
$3,530,830 |
$5,499,522 |
| Total People Bought |
0 |
2 |
2 |
3 |
| Total Buy Transactions |
0 |
4 |
14 |
17 |
| Total Shares Sold |
92,351 |
249,644 |
399,644 |
399,644 |
| Total Sell Value |
$1,118,618 |
$2,239,854 |
$3,035,237 |
$3,035,237 |
| Total People Sold |
2 |
4 |
4 |
4 |
| Total Sell Transactions |
4 |
10 |
12 |
12 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wedell-Wedellsborg Johan |
Director |
– • – |
2019-09-06 |
4 |
S |
$27.00 |
$156,357 |
I/I |
(5,791) |
498,392 |
|
- |
|
| Wedell-Wedellsborg Johan |
Director |
– • – |
2019-09-05 |
4 |
S |
$27.00 |
$309,204 |
I/I |
(11,452) |
504,183 |
|
- |
|
| Gad Thomas |
President and Chairman |
• • – |
2019-09-03 |
4 |
AS |
$25.77 |
$103,081 |
I/I |
(4,000) |
896,000 |
|
- |
|
| Wedell-Wedellsborg Johan |
Director |
– • • |
2019-08-30 |
4 |
S |
$27.00 |
$2,700 |
I/I |
(100) |
515,635 |
|
- |
|
| Wedell-Wedellsborg Johan |
Director |
– • • |
2019-08-29 |
4 |
S |
$26.58 |
$2,367,374 |
I/I |
(89,066) |
515,735 |
|
- |
|
| Raskin Gregory S |
Director |
– • – |
2019-08-29 |
4 |
S |
$26.70 |
$157,026 |
D/D |
(5,882) |
0 |
|
- |
|
| Wedell-Wedellsborg Johan |
Director |
– • • |
2019-08-28 |
4 |
S |
$27.02 |
$798,495 |
I/I |
(29,552) |
604,801 |
|
- |
|
| Wedell-Wedellsborg Johan |
Director |
– • • |
2019-08-27 |
4 |
S |
$27.18 |
$538,300 |
I/I |
(19,805) |
634,353 |
|
- |
|
| Wedell-Wedellsborg Johan |
Director |
– • • |
2019-08-22 |
4 |
S |
$27.75 |
$27,473 |
I/I |
(990) |
654,158 |
|
- |
|
| Wedell-Wedellsborg Johan |
Director |
– • • |
2019-08-21 |
4/A |
S |
$27.83 |
$1,673,028 |
I/I |
(60,116) |
655,148 |
|
- |
|
| Wedell-Wedellsborg Johan |
Director |
– • • |
2019-08-21 |
4 |
S |
$27.83 |
$1,673,028 |
I/I |
(60,116) |
664,147 |
|
- |
|
| Wedell-Wedellsborg Johan |
Director |
– • • |
2019-08-20 |
4/A |
S |
$27.42 |
$2,964,870 |
I/I |
(108,128) |
715,264 |
|
- |
|
| Wedell-Wedellsborg Johan |
Director |
– • • |
2019-08-20 |
4 |
S |
$27.42 |
$2,964,870 |
I/I |
(108,128) |
724,263 |
|
- |
|
| Gad Thomas |
President and Chairman |
• • – |
2019-08-19 |
4 |
AS |
$27.70 |
$110,805 |
I/I |
(4,000) |
900,000 |
|
- |
|
| Gad Thomas |
President and Chairman |
• • – |
2019-08-05 |
4 |
AS |
$21.78 |
$87,106 |
I/I |
(4,000) |
904,000 |
|
- |
|
| Gad Thomas |
President and Chairman |
• • – |
2019-07-22 |
4 |
AS |
$22.54 |
$90,177 |
I/I |
(4,000) |
908,000 |
|
- |
|
| Wedell-Wedellsborg Johan |
Director |
– • • |
2019-07-15 |
4/A |
D |
$0.00 |
$0 |
I/I |
(860,105) |
823,392 |
|
- |
|
| Wedell-Wedellsborg Johan |
Director |
– • • |
2019-07-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(860,105) |
832,391 |
|
- |
|
| Gad Thomas |
President and Chairman |
• • – |
2019-07-08 |
4 |
AS |
$22.40 |
$89,592 |
I/I |
(4,000) |
912,000 |
|
- |
|
| Gad Thomas |
President and Chariman |
• • – |
2019-06-24 |
4 |
AS |
$21.77 |
$87,098 |
I/I |
(4,000) |
916,000 |
|
- |
|
| Gad Thomas |
President and Chairman |
• • – |
2019-06-10 |
4 |
AS |
$22.79 |
$91,166 |
I/I |
(4,000) |
920,000 |
|
- |
|
| Gad Thomas |
President and Chairman |
• • – |
2019-06-03 |
4 |
AS |
$20.03 |
$80,121 |
I/I |
(4,000) |
924,000 |
|
- |
|
| Gad Thomas |
President and Chairman |
• • – |
2019-05-28 |
4 |
AS |
$20.21 |
$121,252 |
I/I |
(6,000) |
928,000 |
|
- |
|
| Gad Thomas |
President and Chairman |
• • – |
2019-05-13 |
4 |
AS |
$20.61 |
$123,647 |
I/I |
(6,000) |
934,000 |
|
- |
|
| Gad Thomas |
President and Chairman |
• • – |
2019-04-11 |
4 |
S |
$25.80 |
$3,870,000 |
I/I |
(150,000) |
940,000 |
|
- |
|
255 Records found
|
|
Page 10 of 11 |
|
|
0.09 (0.75%) 
